ArticleOncotarget2018

Ovatodiolide targets chronic myeloid leukemia stem cells by epigenetically upregulating hsa-miR-155, suppressing the BCR-ABL fusion gene and dysregulating the PI3K/AKT/mTOR pathway.

Yue-Xing Tu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.